Rubius Therapeutics, Inc. Recorded Big Gain

Mon, Apr 25, 2022 at 05:30 PM
Rubius Therapeutics, Inc. Recorded Big Gain

Rubius Therapeutics, Inc. (RUBY:NASDAQ) soared at $1.87, a gain of 40.6%. On Fri, Apr 22, 2022, RUBY:NASDAQ touched a New 2-Week Intraday Low of $1.18. The stock appeared on our News Catalysts scanner on Fri, Apr 08, 2022 at 01:09 PM in the 'BIOTECH' category. From Fri, Apr 08, 2022, the stock recorded 22.22% Up Days and 10.00% Green Days

About Rubius Therapeutics, Inc. (RUBY:NASDAQ)

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.